Glucose variability has been suspected to be a major factor of diabetic complications. Several indices have been proposed for measuring glucose variability, but their interest remains discussed. Our aim was to compare different indices.
Methods:
Glucose variability was studied in 150 insulin-treated diabetic patients (46% men, 42% type 1 diabetes, age 52 ± 11 years) using a continuous glucose monitoring system (668 ± 564 glucose values; mean glucose value 173 ± 38 mg/dL). Results from the mean, the median, different indices (SD, MAGE, MAG, glucose fluctuation index (GFI), and percentages of low [<60 mg/dL] and high [>180 mg/dL] glucose values), and ratios (CV = SD/m, MAGE/m, MAG/m, and GCF = GFI/m) were compared using Pearson linear correlations and a multivariate principal component analysis (PCA).
Results:
CV, MAGE/m (ns), GCF and GFI (P < .05), MAG and MAG/m (P < .01) were not strongly correlated with the mean. The percentage of high glucose values was mainly correlated with indices. The percentage of low glucose values was mainly correlated with ratios. PCA showed 3 main axes; the first was associated with descriptive data (mean, SD, CV, MAGE, MAGE/m, and percentage of high glucose values); the second with ratios MAG/m and GCF and with the percentage of low glucose values; and the third with MAG, GFI, and the percentage of high glucose values.
Conclusions:
Indices and ratios provide complementary pieces of information associated with high and low glucose values, respectively. The pairs MAG+MAG/m and GFI+GCF appear to be the most reliable markers of glucose variability in diabetic patients.
DeVriesJH.Glucose variability: where it is important and how to measure it. Diabetes. 2013;62:1405-1408.
3.
BrownleeM.Biochemistry and molecular cell biology of diabetic complications. Nature. 2001;414:813-820.
4.
CerielloAEspositoKPiconiL. Oscillating glucose is more deleterious to endothelial function and oxidative stress than mean glucose in normal and type 2 diabetic patients. Diabetes. 2008;57:1349-1354.
5.
MonnierLMasEGinetC. Activation of oxidative stress by acute glucose fluctuations compared with sustained chronic hyperglycemia in patients with type 2 diabetes. JAMA. 2006;295:1681-1687.
6.
MonnierLColetteCMasE. Regulation of oxidative stress by glycaemic control: evidence for an independent inhibitory effect of insulin therapy. Diabetologia. 2010;53:562-571.
7.
HermanidesJVriesendorpTMBosmanRJZandstraDFHoekstraJBDeVriesJH.Glucose variability is associated with intensive care unit mortality. Crit Care Med. 2010;38:838-842.
8.
EslamiSTaherzadehZSchultzMJAbu-HannaA.Glucose variability measures and their effect on mortality: a systematic review. Intensive Care Med. 2011;37:583-593.
9.
KilpatrickESRigbyASAtkinSL.The effect of glucose variability on the risk of microvascular complications in type 1 diabetes. Diabetes Care. 2006;29:1486-1490.
10.
SiegelaarSEKilpatrickESRigbyASAtkinSLHoeskstraJBDeVriesJH.Glucose variability does not contribute to the development of peripheral and autonomic neuropathy in type 1 diabetes; data from the DCCT. Diabetologia. 2009;52:2229-2232.
11.
SiegelaarSEBarwariTKulikWHoestraJBDeVriesJH.No relevant relationship between glucose variability and oxidative stress in well-regulated type 2 diabetes patients. J Diabetes Sci Technol. 2011;5:86-92.
12.
RodbardD.Optimizing display, analysis, interpretation and utility of self-monitoring of blood-glucose (SMBG) data for management of patients with diabetes. J Diabetes Sci Technol. 2007;1:62-71.
13.
RodbardD.Interpretation of continuous monitoring data : glycemic variability and quality of glycemic control. Diabetes Technol Ther. 2009;11(suppl 1):S55-S67.
14.
WentholtIMKulikWMichelsRPHoekstraJBDeVriesJH.Glucose fluctuations and activation of oxidative stress in patients with type 1 diabetes. Diabetologia. 2008;51:183-190.
15.
BragdJAdamsonUBacklundLBLinsPEMobergEOskarsonP.Can glycemic variability, as calculated from blood glucose self-monitoring, predict the development of complications in type 1 diabetes over a decade ?Diabetes Metab. 2008;34:612-616.
16.
BergensalRMAhmannAJBaileyT. Recommendations for standardizing glucose reporting and analysis to optimize clinical decision making in diabetes: the ambulatory glucose profile (AGP). Diabetes Technol Ther. 2013;15:198-211.
17.
ServiceFJMolnarGDRosevearJWAckermanEGatewoodLCTaylorWF.Mean amplitude of glycemic excursions, a measure of diabetic instability. Diabetes. 1970;19:644-655.
18.
BaghurstP.Calculating the mean amplitude of glycemic excursion from continuous glucose monitoring data: an automated algorithm. Diabetes Technol Ther. 2011;13:296-302.
19.
RodbardD.New and improved methods to characterize glycemic variability using continuous glucose monitoring. Diabetes Technol Ther. 2009;11:551-565.
20.
SiegelaarSEHollemanFHoekstraJBDeVriesJH.Glucose variability: does it matter?Endocr Rev. 2010;31:171-182.
21.
MobergEKollindMLinsPEAdamsonU.Estimation of blood-glucose variability in patients with insulin-dependent diabetes mellitus. Scand J Clin Lab Invest. 1993;53:507-514.
KovatchevBPCoxDJGonder-FrederickLAClarkeW.Symmetrisation of the blood glucose measurement scale and its applications. Diabetes Care. 1997;20:1655-1658.
24.
HillNRHindmarshPCStevensRJStrattonIMLevyJCMattewsDR.a method for assessing quality of control from glucose profiles. Diabet Med. 2007;24:753-758.
25.
MazzeRSStrockEWesleyD. Characterizing glucose exposure for individuals with normal glucose tolerance using continuous glucose monitoring and ambulatory glucose profile analysis. Diabetes Technol Ther. 2008;10:149-159.
26.
Shapiro BraithwaiteS. Multiplicative standard deviation for blood glucose. Diabetes Technol Ther. 2014;16:195-197.
27.
CrenierL.Poincaré plot quantification for assessing glucose variability from continuous glucose monitoring systems and a new risk marker for hypoglycemia: application to type 1 diabetes patients switching to continuous subcutaneous insulin infusion. Diabetes Technol Ther. 2014;16:247-254.
28.
RodbardD.Clinical interpretation of indices of quality of glycemic control and glycemic variability. Postgrad Med. 2011;123:107-118.
29.
DunganKM.1,5-anhydroglucitol (Glycomark) as a marker of short-term glycemic control and glycemic excursions. Expert Rev Mol Diagn. 2008;8:9-19.
30.
CohenMBElderSMuscoCNMuscoCPPersuM.Dimensional reduction for k-means clustering and low rank approximation. Available at: http://arxiv.org/pdf/1410.6801. Accessed October 30, 2015.
31.
Snell-BergeonJKRomanRRodbardD. Glycemic variability is associated with coronary artery calcium in men with type 1 diabetes: the coronary artery calcification in type 1 diabetes study. Diabet Med. 2010;27:1436-1442.
32.
SiegelaarSEKerrLJacoberSJDeVriesJH.A decrease in glucose variability does not reduce cardiovascular event rates in type 2 diabetic patients after myocardial infarction: a reanalysis of the HEART2D trial. Diabetes Care. 2011;34:855-857.
33.
MeynaarIAEslamiSAbu-HannaAVan der VoortPDe LangeDWDe KeizerN.Blood glucose amplitude variability as predictor for mortality in surgical and medical intensive care unit patients: a multicenter cohort study. J Crit Care. 2012;27:119-124.
34.
FacchinettiASparacinoGGuerraS. Real-time improvement of continuous glucose monitoring accuracy: the smart sensor concept. Diabetes Care. 2013;36:793-800.
35.
Von NeumannJ. Distribution of the ratio of the mean square successive difference to the variance. Ann Math Statist. 1941;12:367-395.
36.
BerntsonGLozanoDLChenYJ.Filter properties of root mean square successive difference (RMMSD) for heart rate. Psychophysiology. 2005;42:246-252.
MoriYTaniguchiYSezakiKYokoyamaJUtsonomiyaK.Liraglutide narrows the range of circadian glycemic variations in Japanese type 2 diabetes patients and nearly flattens these variations in drug-naive type 2 diabetes patients : a continuous glucose monitoring-based study. Diabetes Technol Ther. 2011;13:1139-1144.
39.
MonnierLColetteC.Glycemic variability: should we and can we prevent it?Diabetes Care. 2008;31(suppl 2):S150-S154.
40.
ThomasASchönauerMAchermannF. The “glucose pentagon”: assessing glycemic control of patients with diabetes mellitus by a model integrating different parameters from glucose profiles. Diabetes Technol Ther. 2009;11:399-409.
41.
GorstCKwokCSAslamS. Long-term glycemic variability and risk of adverse outcomes: a systematic review and meta-analysis. Diabetes Care. 2015;38:2354-2369.
